SCHEMBL6565685

SCHEMBL6565685

CCOC(=O)CCNC(=O)Nc1ccc(C)cc1O

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.50
ALDH1A1 P00352 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
KMT2A Q03164 5/20 0.45
MEN1 O00255 3/20 0.45
NLRP3 Q96P20 1/20 0.45
HTT P42858 1/20 0.44
PTPN7 P35236 1/20 0.43
GAA P10253 3/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
POLB P06746 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4347692 0.90 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2KMT2AMEN1HTT
SCHEMBL8194387 0.83 MAPT (0.58) CXCR2ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL6836163 0.80 CXCR2 (0.57) CXCR2ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL14224546 0.80 CXCR2 (0.60) CXCR2CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4345348 0.80 EPHX2 (0.56) CXCR2ALDH1A1KMT2AMEN1HTT
SCHEMBL4349661 0.80 MEN1 (0.67) ALDH1A1CYP1A2CYP2C19KMT2AMEN1
SCHEMBL8600374 0.78 EPHX2 (0.58) CXCR2ALDH1A1KMT2AMEN1HTT
SCHEMBL4353720 0.77 HTT (0.60) CXCR2ALDH1A1KMT2AMEN1NLRP3
SCHEMBL6565629 0.75 CXCR2 (0.62) CXCR2ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL28608254 0.75 CYP1A2 (0.51) CXCR2ALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed